Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population

Liang Zeng, Lili Xiao, Wenjuan Jiang, Haiyan Yang, Dandan Hu, Chen Xia, Yizhi Li, Chunhua Zhou, Yi Xiong, Li Liu, Dehua Liao, Rui Guan, Kunyan Li, Jing Wang, Yongchang Zhang, Nong Yang, Aaron S. Mansfield

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population'. Together they form a unique fingerprint.

Medicine & Life Sciences